55 North Mining

Nine Mile Metals Announces Certified High-Grade Assay Results up to 15.00% Copper from the Wedge Project, Bathurst, New Brunswick

Nine Mile Metals LTD. (CSE: NINE,OTC:VMSXF) (OTC Pink: VMSXF) (FSE: KQ9) (the ‘Company’ or ‘Nine Mile’) is pleased to announce Certified Assay

Apollo Silver Announces $2.5 Million Upsize to Previously Announced Financing to Allow for Insider Participation

Apollo Silver Corp. (‘Apollo Silver’ or the ‘Company’) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF) is pleased to announce that it has upsized its previously announced

International Lithium Corp. Updates on Lepidico Arbitration Determination

International Lithium Corp. (TSXV: ILC,OTC:ILHMF) (OTCQB: ILHMF) (FSE: IAH) (the ‘Company’ or ‘ILC’) announces that on December 24, 2025, it received the

Managing Director Resignation and Board Changes

Blackstone Minerals (BSX:AU) has announced Managing Director Resignation and Board Changes Download the PDF here. This post appeared first on investingnews.com

Rick Rule, Ed Steer, Vince Lanci and More — Our Top 5 Interviews of the Year

Don Durrett: Gold, Silver Price Targets and 15 ‘Must-Own’ Silver Stocks Kicking off the list in the fifth spot is Don Durrett of

Jeffrey Christian: Gold, Silver at Record Prices, Expect Spikes Higher in 2026

Jeffrey Christian, managing partner at CPM Group, shares his outlook for gold and silver in 2026, explaining why he expects higher prices

Altius Minerals to Expand Portfolio with C$520 Million Lithium Royalty Deal

Altius Minerals (TSX:ALS,OTCQX:ATUSF) is making a bet on a lithium market recovery, agreeing to acquire Lithium Royalty (TSX:LIRC) in a C$520 million

Craig Hemke: Silver, Gold’s “Outstanding” Year — Will 2026 Bring a Repeat?

Craig Hemke, publisher of TFMetalsReport.com, shares his thoughts on the gold and silver markets heading into 2026, outlining why he remains bullish. ‘Just

Biotech Market Forecast: Top Trends for Biotech in 2026

The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology momentum and supportive policy tailwinds. This